Quality-of-life outcomes from the Prostate Adenocarcinoma: TransCutaneous Hormones (PATCH) trial evaluating luteinising hormone-releasing hormone agonists versus transdermal oestradiol for androgen suppression in advanced prostate cancer. (2017)
Attributed to:
CANCER: Trials with potential global reach and other challenging trials
funded by
MRC
Abstract
No abstract provided
Bibliographic Information
Digital Object Identifier: http://dx.doi.org/10.1111/bju.13687
PubMed Identifier: 27753182
Publication URI: http://europepmc.org/abstract/MED/27753182
Type: Journal Article/Review
Volume: 119
Parent Publication: BJU international
Issue: 5
ISSN: 1464-4096